Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 3
2011 4
2012 1
2013 1
2016 2
2017 1
2018 4
2019 1
2020 7
2021 3
2022 4
2023 10
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Immunoglobulin M Paraproteinaemias.
Girard LP, Soekojo CY, Ooi M, Poon LM, Chng WJ, de Mel S. Girard LP, et al. Among authors: ooi m. Cancers (Basel). 2020 Jun 25;12(6):1688. doi: 10.3390/cancers12061688. Cancers (Basel). 2020. PMID: 32630470 Free PMC article. Review.
Immunotherapy in Multiple Myeloma.
Soekojo CY, Ooi M, de Mel S, Chng WJ. Soekojo CY, et al. Among authors: ooi m. Cells. 2020 Mar 3;9(3):601. doi: 10.3390/cells9030601. Cells. 2020. PMID: 32138182 Free PMC article. Review.
Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis.
Guo M, Chan THM, Zhou Q, An O, Li Y, Song Y, Tan ZH, Ng VHE, Peramangalam PS, Tan ZQ, Cao X, Iwanaga E, Matsuoka M, Ooi MGM, Jen WY, Koh LP, Chan E, Tan LK, Goh Y, Wang W, Koh BTH, Chun CM, Fullwood MJ, Chng WJ, Osato M, Pulikkan JA, Yang H, Chen L, Tenen DG. Guo M, et al. Among authors: ooi mgm. Blood. 2023 Jun 22;141(25):3078-3090. doi: 10.1182/blood.2022015830. Blood. 2023. PMID: 36796022
Response-Adapted Therapy for Newly Diagnosed Multiple Myeloma.
Teo WZY, Ong IYE, Tong JWY, Ong WL, Lin A, Song F, Tai BC, Ooi M, Seokojo CY, Chen Y, Nagarajan C, Chng WJ, de Mel S. Teo WZY, et al. Among authors: ooi m. Curr Hematol Malig Rep. 2023 Oct;18(5):190-200. doi: 10.1007/s11899-023-00704-9. Epub 2023 Jul 4. Curr Hematol Malig Rep. 2023. PMID: 37400631 Review.
Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group.
Gill H, Leung GMK, Ooi MGM, Teo WZY, Wong CL, Choi CW, Wong GC, Lao Z, Rojnuckarin P, Castillo MRID, Xiao Z, Hou HA, Kuo MC, Shih LY, Gan GG, Lin CC, Chng WJ, Kwong YL. Gill H, et al. Among authors: ooi mgm. Clin Exp Med. 2023 Dec;23(8):4199-4217. doi: 10.1007/s10238-023-01189-9. Epub 2023 Sep 25. Clin Exp Med. 2023. PMID: 37747591 Review.
Immunoglobulin M Monoclonal Gammopathies of Clinical Significance.
Girard LP, Soekojo CY, Ooi M, Chng WJ, de Mel S. Girard LP, et al. Among authors: ooi m. Front Oncol. 2022 Jun 9;12:905484. doi: 10.3389/fonc.2022.905484. eCollection 2022. Front Oncol. 2022. PMID: 35756635 Free PMC article. Review.
Risk Stratification in Multiple Myeloma.
Ooi MG, de Mel S, Chng WJ. Ooi MG, et al. Curr Hematol Malig Rep. 2016 Apr;11(2):137-47. doi: 10.1007/s11899-016-0307-4. Curr Hematol Malig Rep. 2016. PMID: 26883334 Review.
Pan-cancer pervasive upregulation of 3' UTR splicing drives tumourigenesis.
Chan JJ, Zhang B, Chew XH, Salhi A, Kwok ZH, Lim CY, Desi N, Subramaniam N, Siemens A, Kinanti T, Ong S, Sanchez-Mejias A, Ly PT, An O, Sundar R, Fan X, Wang S, Siew BE, Lee KC, Chong CS, Lieske B, Cheong WK, Goh Y, Fam WN, Ooi MG, Koh BTH, Iyer SG, Ling WH, Chen J, Yoong BK, Chanwat R, Bonney GK, Goh BKP, Zhai W, Fullwood MJ, Wang W, Tan KK, Chng WJ, Dan YY, Pitt JJ, Roca X, Guccione E, Vardy LA, Chen L, Gao X, Chow PKH, Yang H, Tay Y. Chan JJ, et al. Among authors: ooi mg. Nat Cell Biol. 2022 Jun;24(6):928-939. doi: 10.1038/s41556-022-00913-z. Epub 2022 May 26. Nat Cell Biol. 2022. PMID: 35618746 Free PMC article.
A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies.
Chee CE, Ooi M, Lee SC, Sundar R, Heong V, Yong WP, Ng CH, Wong A, Lim JSJ, Tan DSP, Soo R, Tan JTC, Yang S, Thura M, Al-Aidaroos AQ, Chng WJ, Zeng Q, Goh BC. Chee CE, et al. Among authors: ooi m. Target Oncol. 2023 May;18(3):391-402. doi: 10.1007/s11523-023-00962-w. Epub 2023 Apr 15. Target Oncol. 2023. PMID: 37060431 Free PMC article. Clinical Trial.
40 results